Tower Research Capital (TRC)’s Advanced Health Intelligence Ltd AHI Stock Holding History

Tower Research Capital (TRC)’s Portfolio AHI Stock Details AHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-550	Closed	-$2.11K	–	6519
2023 Q2	$2.11K	Buy	+550	New	+$1.24K	﹤0.01%	5250
2022 Q1	–	Sell	-4,828	Closed	-$94K	–	7214
2021 Q4	$94K	Buy	+4,828	New	+$90.7K	﹤0.01%	2271

Other funds holding AHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Tower Research Capital (TRC)'s AHI Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of Advanced Health Intelligence Ltd (AHI) in Q3 2023, closing a stake of 550 shares — an estimated $2.11K sold.

Tower Research Capital (TRC) first reported a position in AHI in Q4 2021 and held it in 2 quarters. The position peaked at $94K in Q4 2021. 6 funds tracked by Wall St. Rank hold AHI as of Q3 2023.

Tower Research Capital (TRC) reported no remaining Advanced Health Intelligence Ltd position as of Q3 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 550 Advanced Health Intelligence Ltd shares in Q3 2023, an estimated $2.11K.
Tower Research Capital (TRC) first reported a position in Advanced Health Intelligence Ltd in Q4 2021 and held it in 2 quarters.
Tower Research Capital (TRC)'s Advanced Health Intelligence Ltd position peaked at $94K in Q4 2021.
6 funds tracked by Wall St. Rank held Advanced Health Intelligence Ltd as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.